Kumar Nanjagowder MD, MS, CMD

Dr. Nanjagowder is a fellowship-trained geriatrician and certified medical director with over two decades of clinical experience in family medicine and geriatrics, including the management of complex chronic conditions such as Alzheimer’s disease, Parkinson’s disease, Cardiovascular disease, Metabolic disease, and other chronic disorders. With a robust foundation in both patient care and research, Dr. Nanjagowder has contributed to clinical trials across phases I–IV and served as a speaker and consultant for pharmaceutical leaders, including Eisai, Janssen, Eli Lilly, and Pfizer. He recently served as Director of Medical Affairs in industry, where he led strategy development, KOL engagement, and cross-functional collaboration. Known for blending scientific expertise with patient-centered advocacy, Dr. Nanjagowder remains committed to improving outcomes through innovation in both clinical and research settings. Passionate about advancing patient outcomes, he brings a unique blend of medical insight, collaborative leadership, and scientific rigor to every role.